RIGCEF-XP 1.125 Injection is a powerful combination antibiotic used for the treatment of a wide range of bacterial infections. It contains Ceftriaxone, a third-generation cephalosporin antibiotic, and Tazobactam, a beta-lactamase inhibitor that enhances the antibiotic’s effectiveness against resistant bacteria.
This synergistic combination works effectively against infections of the respiratory tract, urinary tract, abdominal cavity, skin, bones, and joints, providing quick relief and superior bacterial control.
Key Benefits
-
Provides broad-spectrum antibacterial protection
-
Effective against beta-lactamase producing bacteria
-
Helps in faster recovery from severe infections
-
Ensures enhanced efficacy and reduced bacterial resistance
-
Suitable for hospital-acquired and community-acquired infections
Indications
RIGCEF-XP 1.125 Injection is indicated for the treatment of:
-
Lower and upper respiratory tract infections
-
Urinary tract infections (UTI)
-
Intra-abdominal infections
-
Skin and soft tissue infections
-
Bone and joint infections
-
Gynecological and post-surgical infections
-
Septicemia and bacterial meningitis (as prescribed by a physician)
Dosage & Administration
-
Dosage should be determined by a registered medical practitioner based on infection severity and patient condition.
-
Administered by intravenous (IV) or intramuscular (IM) route.
-
Reconstitution: Use sterile water for injection or as directed by a physician.
-
Do not self-administer.
Ingredients
-
Active Ingredients:
-
Ceftriaxone Sodium – 1000 mg
-
Tazobactam Sodium – 125 mg
-
-
Excipients: As required for reconstitution and stability
Storage
-
Store below 25°C in a cool, dry, and dark place
-
Keep out of reach of children
Why Choose RIGCEF-XP 1.125 Injection?
-
A trusted formulation for treating multi-resistant bacterial infections
-
Clinically tested for safety and efficacy
-
Manufactured under strict quality standards
-
Reliable results with minimal side effects when used as prescribed
Reviews
There are no reviews yet.